ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Zhang J , Hobkirk J , Carroll S , Pellicori P , Clark AL , Cleland JGF , 2016. Exploring quality of life in patients with and without heart failure. Int J Cardiol 202: 676–684.
-
2.
Olivera MJ , Buitrago G , 2020. Economic costs of Chagas disease in Colombia in 2017: a social perspective. Int J Infect Dis 91: 196–201.
-
3.
Park J , Moser DK , Griffith K , Harring JR , Johantgen M , 2019. Exploring symptom clusters in people with heart failure. Clin Nurs Res 28: 165–181.
-
4.
Zhang Y , Yuan M , Gong M , Tse G , Li G , Liu T , 2018. Frailty and clinical outcomes in heart failure: a systematic review and meta-analysis. J Am Med Dir Assoc 19: 1003–1008.e1.
-
5.
Olivera MJ , Villamil JFP , Gahona CCT , Hernández JMR , 2018. Barriers to diagnosis access for Chagas disease in Colombia. J Parasitol Res 2018: 4940796.
-
6.
Salyer J , Flattery M , Lyon DE , 2019. Heart failure symptom clusters and quality of life. Heart Lung 48: 366–372.
-
7.
Juenger J , Schellberg D , Kraemer S , Haunstetter A , Zugck C , Herzog W , Haass M , 2002. Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables. Heart 87: 235–241.
-
8.
Megari K , 2013. Quality of life in chronic disease patients. Heal Psychol Res 1: e27.
-
9.
Sousa GR , Costa HS , Souza AC , Nunes MC , Lima MM , Rocha MO , 2015. Health-related quality of life in patients with Chagas disease: a review of the evidence. Rev Soc Bras Med Trop 48: 121–128.
-
10.
Olivera MJ , Fory JA , Porras JF , Buitrago G , 2019. Prevalence of Chagas disease in Colombia: a systematic review and meta-analysis. PLoS One 14: e0210156.
-
11.
Comin-Colet J , Anguita M , Formiga F , Almenar L , Crespo-Leiro MG , Manzano L , Muniz J , Chaves J , de Frutos T , Enjuanes C , 2016. Health-related quality of life of patients with chronic systolic heart failure in Spain: results of the VIDA-IC study. Rev Esp Cardiol 69: 256–271.
-
12.
Rector TS , Kubo S , Cohn JN , 1987. Patients’ self-assessment of their congestive heart failure, part 2: content, reliability and validity of a new measure, the Minnesota Living with Heart Failure Questionnaire. Heart Fail 3: 198–209.
-
13.
Rector TS , Cohn JN , 1992. Assessment of patient outcome with the Minnesota living with heart failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group. Am Heart J 124: 1017–1025.
-
14.
Green CP , Porter CB , Bresnahan DR , Spertus JA , 2000. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J Am Coll Cardiol 35: 1245–1255.
-
15.
Kluthcovsky ACGC , Urbanetz AA , 2015. Fatigue and quality of life in breast cancer survivors: a comparative study. Rev Bras Ginecol Obstet 37: 119–126.
-
16.
Claridy MD , Ansa B , Damus F , Alema-Mensah E , Smith SA , 2018. Health-related quality of life of African-American female breast cancer survivors, survivors of other cancers, and those without cancer. Qual Life Res 27: 2067–2075.
-
17.
Goswami S , Mongelli M , Peipert BJ , Helenowski I , Yount SE , Sturgeon C , 2018. Benchmarking health-related quality of life in thyroid cancer versus other cancers and United States normative data. Surgery 164: 986–992.
-
18.
Cesáreo Naveiro-Rilo J , Diez-Juárez MD , Flores-Zurutuza L , Rodríguez-García MÁ , Rebollo-Gutiérrez F , Romero Blanco A , 2012. La calidad de vida en los enfermos con insuficiencia cardiaca: visión desde atención primaria de salud. Gac Sanit 26: 436–443.
-
19.
Santos-Filho JCL et al. 2018. Quality of life and associated factors in patients with chronic Chagas disease. Trop Med Int Health 23: 1213–1222.
-
20.
Pelegrino VM , Dantas RAS , Ciol MA , Clark AM , Rossi LA , Simoes MV , 2011. Health-related quality of life in Brazilian outpatients with Chagas and non-Chagas cardiomyopathy. Heart Lung 40: e25–e31.
-
21.
Oliveira BG , Abreu MNS , Abreu CDG , Rocha MO , Ribeiro AL , 2011. Health-related quality of life in patients with Chagas disease. Rev Soc Bras Med Trop 44: 150–156.
-
22.
Dourado KC , Bestetti RB , Cordeiro JA , Theodoropoulos TA , 2006. Assessment of quality of life in patients with chronic heart failure secondary to Chagas’ cardiomyopathy. Int J Cardiol 108: 412–413.
-
23.
Hauptman PJ , Masoudi FA , Weintraub WS , Pina I , Jones PG , Spertus JA , 2004. Variability in the clinical status of patients with advanced heart failure. J Card Fail 10: 397–402.
-
24.
Ritt LE , Carvalho AC , Feitosa GS , Pinho-Filho JA , Andrade MVS , Feitosa-Filho GS , Newby LK , Lopes RD , 2013. Cardiopulmonary exercise and 6-min walk tests as predictors of quality of life and long-term mortality among patients with heart failure due to Chagas disease. Int J Cardiol 168: 4584–4585.
-
25.
Costa HS , Alves RL , da Silva SA , Alencar MC , Nunes Mdo CP , Lima MM , Rocha MO , 2014. Assessment of functional capacity in Chagas heart disease by incremental shuttle walk test and its relation to quality-of-life. Int J Prev Med 5: 152–158.
-
26.
Vieira FC , de Melo Marinho PE , Brandao DC , Barbosae e Silva O , 2014. Respiratory muscle strength, the six-minute walk test and quality of life in Chagas cardiomyopathy. Physiother Res Int 19: 8–15.
-
27.
Chambela MDC et al. 2020. Impact of pharmaceutical care on the quality of life of patients with heart failure due to chronic Chagas disease: randomized clinical trial. Br J Clin Pharmacol 86: 143–154.
-
28.
Evangelista LS , Moser DK , Westlake C , Hamilton MA , Fonarow GC , Dracup K , 2006. Impact of obesity on quality of life and depression in patients with heart failure. Eur J Heart Fail 8: 750–755.
-
29.
Horwich TB , Fonarow GC , Clark AL , 2018. Obesity and the obesity paradox in heart failure. Prog Cardiovasc Dis 61: 151–156.
-
30.
Yap J et al. 2019. Association of diabetes mellitus on cardiac remodeling, quality of life, and clinical outcomes in heart failure with reduced and preserved ejection fraction. J Am Heart Assoc 8: e013114.
-
31.
Kewcharoen J , Thangjui S , Kanitsoraphan C , Techorueangwiwat C , Mekraksakit P , Vutthikraivit W , 2019. The effects of marital status on outcome of heart failure population: a systematic review and meta-analysis. Acta Cardiol 1–9.
-
32.
Fabbri M , Yost K , Finney Rutten LJ , Manemann SM , Boyd CM , Jensen D , Weston SA , Jiang R , Roger VL , 2018. Health literacy and outcomes in patients with heart failure: a prospective community study. Mayo Clin Proc 93: 9–15.
-
33.
Santos JJA , Plewka JEA , Brofman PRS , 2009. Quality of life and clinical indicators in heart failure: a multivariate analysis. Arq Bras Cardiol 93: 159–166.
-
34.
Grigioni F et al. 2003. Distance between patients’ subjective perceptions and objectively evaluated disease severity in chronic heart failure. Psychother Psychosom 72: 166–170.
-
35.
Costa HS , Lima MM , Figueiredo PHS , Chaves AT , Nunes MC , Rocha MO , 2019. The prognostic value of health-related quality of life in patients with Chagas heart disease. Qual Life Res 28: 67–72.
-
36.
Shen L et al. 2017. Contemporary characteristics and outcomes in Chagasic heart failure compared with other nonischemic and ischemic cardiomyopathy. Circ Heart Fail 10: e004361.
-
37.
Morillo CA et al. 2015. Randomized trial of benznidazole for chronic Chagas’ cardiomyopathy. N Engl J Med 373: 1295–1306.
-
38.
Olivera MJ , Cucunuba ZM , Alvarez CA , Nicholls RS , 2015. Safety profile of nifurtimox and treatment interruption for chronic Chagas disease in Colombian adults. Am J Trop Med Hyg 93: 1224–1230.
-
39.
Olivera MJ , Cucunuba ZM , Valencia-Hernandez CA , Herazo R , Agreda-Rudenko D , Florez C , Duque S , Nicholls RS , 2017. Risk factors for treatment interruption and severe adverse effects to benznidazole in adult patients with Chagas disease. PLoS One 12: e0185033.
-
40.
Coelho R , Ramos S , Prata J , Bettencourt P , Ferreira A , Cerqueira-Gomes M , 2005. Heart failure and health related quality of life. Clin Pract Epidemol Ment Health 1: 1–19.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 651 | 7 | 7 |
| Full Text Views | 577 | 205 | 4 |
| PDF Downloads | 215 | 87 | 3 |
Comparison of Health-Related Quality of Life in Outpatients with Chagas and Matched Non-Chagas Chronic Heart Failure in Colombia: A Cross-Sectional Analysis
ABSTRACT
Chagas disease represents an important cause of heart failure (HF) and affects health-related quality of life (HRQoL). The study aimed to evaluate and compare the HRQoL of patients with chagasic HF and matched non-Chagas controls to identify factors associated with HRQoL. A cross-sectional study with pair-matched controls was conducted in Colombia. From October 2018 to December 2019, a total of 84 HF patients were screened for study subjects. Four were excluded, resulting in 80 patients for the analysis, among whom 40 patients with Chagas were enrolled as cases and 40 gender- and age-matched non-Chagas patients as controls. The Kansas City Cardiomyopathy Questionnaire (KCCQ) and the Minnesota Living with Heart Failure Questionnaire (MLWHFQ) were used to measure HRQoL. Demographic, clinical, and laboratory data were obtained from each subject. Health-related quality of life scores were significantly worse among the Chagas group than among the non-Chagas group in the KCCQ domains of physical functioning and symptoms and in the MLWHFQ scale. In the multivariate analysis, the variables associated with lower HRQoL scores were living alone, obesity, having less than 12 years of education, and an increase in left ventricular diameters in the systole and diastole. Health-related quality of life in patients with chronic HF is impaired across all domains. Chagas patients showed worse HRQoL scores than non-Chagas patients. Six variables, some potentially modifiable, were independently associated with worse HRQoL.
Author Notes
Financial support: Funding for this evaluation was provided by the Colombian National Institute of Health.
Authors’ addresses: Mario J. Olivera, Grupo de Parasitología, Instituto Nacional de Salud, Bogotá, D.C., Colombia, E-mail: molivera@ins.gov.co. Johana A. Fory, Facultad de Medicina y Ciencias de la Salud, Universidad Militar Nueva Granada, Bogotá, D.C., Colombia, E-mail: johafory@gmail.com. Giancarlo Buitrago, Instituto de Investigaciones Clínicas, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, D.C., Colombia, and Hospital Universitario Nacional de Colombia, Bogotá, D.C., Colombia, E-mail: gbuitragog@unal.edu.co.